155 related articles for article (PubMed ID: 29119628)
1. STAT3 Expression and Activity are Up-Regulated in Diffuse Large B Cell Lymphoma of Dogs.
Assumpção ALFV; Jark PC; Hong CC; Lu Z; Ruetten HM; Heaton CM; Pinkerton ME; Pan X
J Vet Intern Med; 2018 Jan; 32(1):361-369. PubMed ID: 29119628
[TBL] [Abstract][Full Text] [Related]
2. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma.
Lam LT; Wright G; Davis RE; Lenz G; Farinha P; Dang L; Chan JW; Rosenwald A; Gascoyne RD; Staudt LM
Blood; 2008 Apr; 111(7):3701-13. PubMed ID: 18160665
[TBL] [Abstract][Full Text] [Related]
3. Expression of signal transducer and activator of transcription 3 (STAT3) in primary central nervous system diffuse large B-cell lymphoma: a retrospective analysis of 17 cases.
Vajpayee N; Hussain J; Tolocica I; Hutchison RE; Gajra A
J Neurooncol; 2010 Nov; 100(2):249-53. PubMed ID: 20446017
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways.
Kato H; Karube K; Yamamoto K; Takizawa J; Tsuzuki S; Yatabe Y; Kanda T; Katayama M; Ozawa Y; Ishitsuka K; Okamoto M; Kinoshita T; Ohshima K; Nakamura S; Morishima Y; Seto M
Cancer Sci; 2014 May; 105(5):537-44. PubMed ID: 24581222
[TBL] [Abstract][Full Text] [Related]
5. BCL2 and MYC are expressed at high levels in canine diffuse large B-cell lymphoma but are not predictive for outcome in dogs treated with CHOP chemotherapy.
Curran KM; Schaffer PA; Frank CB; Lana SE; Hamil LE; Burton JH; Labadie J; Ehrhart EJ; Avery PR
Vet Comp Oncol; 2017 Dec; 15(4):1269-1279. PubMed ID: 27514648
[TBL] [Abstract][Full Text] [Related]
6. Cerdulatinib, a novel dual SYK/JAK kinase inhibitor, has broad anti-tumor activity in both ABC and GCB types of diffuse large B cell lymphoma.
Ma J; Xing W; Coffey G; Dresser K; Lu K; Guo A; Raca G; Pandey A; Conley P; Yu H; Wang YL
Oncotarget; 2015 Dec; 6(41):43881-96. PubMed ID: 26575169
[TBL] [Abstract][Full Text] [Related]
7. A phase I clinical trial of systemically delivered NEMO binding domain peptide in dogs with spontaneous activated B-cell like diffuse large B-cell lymphoma.
Habineza Ndikuyeze G; Gaurnier-Hausser A; Patel R; Baldwin AS; May MJ; Flood P; Krick E; Propert KJ; Mason NJ
PLoS One; 2014; 9(5):e95404. PubMed ID: 24798348
[TBL] [Abstract][Full Text] [Related]
8. The rGel/BLyS fusion toxin inhibits STAT3 signaling via down-regulation of interleukin-6 receptor in diffuse large B-cell lymphoma.
Lyu MA; Sung B; Cheung LH; Marks JW; Aggarwal BB; Aguiar RC; Rosenblum MG
Biochem Pharmacol; 2010 Nov; 80(9):1335-42. PubMed ID: 20654581
[TBL] [Abstract][Full Text] [Related]
9. DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway.
Sun X; Li B; Xie B; Xu Z; Chang G; Tao Y; Zhang Y; Chang S; Wang Y; Yu D; Xie Y; Li T; Wang H; Chen G; Hu L; Hou J; Zhang Y; Xiao W; Gao L; Shi J; Zhu W
Cell Death Dis; 2017 Oct; 8(10):e3111. PubMed ID: 29022919
[TBL] [Abstract][Full Text] [Related]
10. Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion.
Momose S; Tamaru J; Kishi H; Mikata I; Mori M; Toyozumi Y; Itoyama S
Hum Pathol; 2009 Jan; 40(1):75-82. PubMed ID: 18755494
[TBL] [Abstract][Full Text] [Related]
11. Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation.
Yao S; Xu F; Chen Y; Ge Y; Zhang F; Huang H; Li L; Lin D; Luo X; Xu J; Luo D; Zhu X; Liu Y
J Exp Clin Cancer Res; 2017 Jan; 36(1):10. PubMed ID: 28069035
[TBL] [Abstract][Full Text] [Related]
12. Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas.
Högfeldt T; Johnsson P; Grandér D; Bahnassy AA; Porwit A; Eid S; Österborg A; Zekri AR; Lundahl J; Khaled MH; Mellstedt H; Moshfegh A
Leuk Lymphoma; 2014 May; 55(5):1158-65. PubMed ID: 23841503
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of FoxP3
Muir CF; Priestnall SL; Hibbert A; Brown C; Garden OA; Scase T
J Comp Pathol; 2017 Jul; 157(1):15-22. PubMed ID: 28735665
[TBL] [Abstract][Full Text] [Related]
14. Expression and significance of leptin receptor, p-STAT3 and p-AKT in diffuse large B-cell lymphoma.
Lin S; YuJun L; XiaoMing X; WenWen R
Acta Histochem; 2014 Jan; 116(1):126-30. PubMed ID: 24054064
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 associated athanogene-1 overexpression in diffuse large B-cell lymphoma.
Ataollahi M; Salehi M; Doostan I; Kabiri Z; Mohajeri M; Mahmoodi F; Shokouhi R; Javan S; Meshkibaf MH; Miladpoor B
Iran J Immunol; 2008 Jun; 5(2):124-30. PubMed ID: 18523358
[TBL] [Abstract][Full Text] [Related]
16. Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma.
Zhang T; Guan XW; Gribben JG; Liu FT; Jia L
Cell Death Dis; 2019 Apr; 10(5):330. PubMed ID: 30988279
[TBL] [Abstract][Full Text] [Related]
17. ISL-1 is overexpressed in non-Hodgkin lymphoma and promotes lymphoma cell proliferation by forming a p-STAT3/p-c-Jun/ISL-1 complex.
Zhang Q; Yang Z; Jia Z; Liu C; Guo C; Lu H; Chen P; Ma K; Wang W; Zhou C
Mol Cancer; 2014 Jul; 13():181. PubMed ID: 25070240
[TBL] [Abstract][Full Text] [Related]
18. PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma.
Brault L; Menter T; Obermann EC; Knapp S; Thommen S; Schwaller J; Tzankov A
Br J Cancer; 2012 Jul; 107(3):491-500. PubMed ID: 22722314
[TBL] [Abstract][Full Text] [Related]
19. Loss of function mutations in PTPN6 promote STAT3 deregulation via JAK3 kinase in diffuse large B-cell lymphoma.
Demosthenous C; Han JJ; Hu G; Stenson M; Gupta M
Oncotarget; 2015 Dec; 6(42):44703-13. PubMed ID: 26565811
[TBL] [Abstract][Full Text] [Related]
20. STAT3-coordinated migration facilitates the dissemination of diffuse large B-cell lymphomas.
Pan YR; Chen CC; Chan YT; Wang HJ; Chien FT; Chen YL; Liu JL; Yang MH
Nat Commun; 2018 Sep; 9(1):3696. PubMed ID: 30209389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]